drugset / Trial / NCT03199560

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

NCT03199560

Phase 4 Unknown 86 enrolled Memorial Health University Medical Center
RandomizedParallel-groupTriple-blindDiagnostic

Summary

A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents Tc 99m tilmanocept to Tc 99m filtered sulfur colloid in breast cancer patients undergoing breast conservation and sentinel lymph node biopsy

Timeline

Start
2017-06-22
Primary completion
2019-06-22
Completion
2019-08-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tilmanocept Diagnostic / imaging agent Other
Comparator filtered sulfur colloid Unknown Other

Indications